IRIS
ROMANO, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.999
EU - Europa 2.874
AS - Asia 1.269
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 9
OC - Oceania 5
Totale 7.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.972
IT - Italia 540
CN - Cina 480
IE - Irlanda 468
UA - Ucraina 450
SE - Svezia 375
GB - Regno Unito 346
TR - Turchia 343
FR - Francia 266
IN - India 220
DE - Germania 163
SG - Singapore 154
FI - Finlandia 92
RU - Federazione Russa 81
CA - Canada 25
AT - Austria 23
VN - Vietnam 22
BE - Belgio 14
HK - Hong Kong 14
PE - Perù 13
CZ - Repubblica Ceca 12
EU - Europa 11
IR - Iran 11
PL - Polonia 11
NL - Olanda 9
BR - Brasile 8
EG - Egitto 8
ES - Italia 8
KR - Corea 7
IL - Israele 6
TW - Taiwan 5
AU - Australia 4
RO - Romania 4
CL - Cile 3
JP - Giappone 3
RS - Serbia 3
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
HR - Croazia 1
MD - Moldavia 1
ME - Montenegro 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.193
Salva come PNG Salva come JPEG
Città #
Chandler 666
Jacksonville 516
Dublin 462
Southend 268
Princeton 207
Izmir 201
Nanjing 132
Singapore 118
Dearborn 112
Ashburn 109
Boardman 107
Chieti 98
Altamura 90
Wilmington 88
Beijing 87
New York 81
Cambridge 80
Ann Arbor 73
Nanchang 63
Rome 40
Santa Clara 39
Montesilvano 34
Los Angeles 30
San Mateo 29
Hebei 24
Washington 24
Woodbridge 24
Vienna 23
Dong Ket 22
Shenyang 22
Jiaxing 21
Kunming 21
Tianjin 21
Falls Church 20
Düsseldorf 19
Augusta 18
Houston 18
Helsinki 15
Brussels 14
Cornaredo 14
Grevenbroich 14
Montreal 13
Central 12
Changsha 12
Milan 11
Toronto 11
Orange 10
San Buono 10
Seattle 10
Brno 9
Pescara 9
Cairo 8
Hangzhou 8
Ica 8
Jinan 8
Lanzhou 7
Leawood 7
Meylan 7
Norwalk 7
Piotrkow Trybunalski 7
Munich 6
Tappahannock 6
Changchun 5
Fuzhou 5
Hefei 5
Lanciano 5
Lima 5
London 5
Madrid 5
Redwood City 5
Saint-prix 5
Vasto 5
Amsterdam 4
Ardabil 4
Auburn Hills 4
Chengdu 4
Chicago 4
Haikou 4
Jundiaí 4
Napoli 4
Ningbo 4
Rochester 4
Saint-Saens 4
Alessandria 3
Assergi 3
Bari 3
Belgrade 3
Casalbordino 3
Clifton 3
Dacun 3
Edinburgh 3
Frankfurt Am Main 3
Guangzhou 3
Moscow 3
Paris 3
Prato 3
Pune 3
Shanghai 3
Taizhou 3
Tokyo 3
Totale 4.395
Salva come PNG Salva come JPEG
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 204
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 130
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 125
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 123
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 123
Mechanisms of endothelial cell dysfunction in cystic fibrosis 121
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 116
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 109
Pentraxin 3 and platelet activation in obese patients after gastric banding 109
Establishment and long-term culture of human cystic fibrosis endothelial cells 108
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 102
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 100
Lipoxins, resolvins, and the resolution of inflammation 96
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 94
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 93
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 92
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 87
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 86
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 85
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 85
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 84
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 82
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 81
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 80
Transcellular regulation of eicosanoids biosyntesis 80
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 80
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 79
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 77
Lipoxin receptors 77
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 77
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 77
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 76
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 75
Homocysteine modulates the CD40/CD40L system 75
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 75
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 75
Increased soluble CD40L levels in cystic fibrosis 74
Leptin increase is associated with markers of the hemostatic system in obese healthy women 74
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 73
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 73
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 73
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 73
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 73
Epigenetic regulation of the formyl peptide receptor 2 gene 72
Induction of functional Lipoxin A4 receptors in HL-60 cells 71
Increased levels of soluble P-selectin in hypercholesterolemic patients 71
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 70
Reduced platelet mitogenic activity in myeloproliferative disorders 70
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 70
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 70
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 70
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 70
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 69
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 69
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 69
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 68
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 67
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 67
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 67
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 67
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 66
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 66
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 66
Lipoxin synthase activity of human platelet 12-Lipoxygenase 65
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 65
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 64
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 64
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 63
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 63
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 63
Inflammation resolution: does the bone marrow have a say? 62
Ligand bias and its association with pro-resolving actions of melanocortin drugs 62
Lipoxin generation by permeabilized human platelets 61
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 61
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 61
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 61
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 61
Lipoxin and aspirin-triggered lipoxins 61
Human alveolar macrophages generate 15-HETE and can produce lipoxins 60
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 60
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 59
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 59
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 58
Endothelial perturbation in cystic fibrosis. 58
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 58
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 57
Lipoxin analogs and lipoxin formation in vivo 57
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 55
Endotoxic Lipid A induces intracellular Ca2+ increase in human platelets 54
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 54
NEW GENETIC AND PHARMACOLOGICAL TREATMENTS FOR CYSTIC FIBROSIS 52
Lower platelet count in centenarians correlates with dispersion of the Q-T interval 51
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 51
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa 50
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 47
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 47
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 45
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics 43
The Resolution Approach to Cystic Fibrosis Inflammation 41
Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis 40
Totale 7.419
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.769
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020864 0 78 5 64 88 68 152 116 33 132 121 7
2020/2021807 102 10 104 27 64 126 54 18 124 104 28 46
2021/2022600 9 14 4 145 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/20241.011 78 46 49 30 57 294 185 51 19 46 22 134
2024/2025320 130 190 0 0 0 0 0 0 0 0 0 0
Totale 7.589